CHRU Lille
CHRU Lille
Lille, France10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopenia | Recruiting | Phase 3 | 2026-09-25 | NCT06449651 | |
| A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) | Hemolytic Disease of the Fetus and Newborn | Recruiting | Phase 3 | 2026-09-25 | NCT05912517 | |
| Dexmedetomidine for Invasive Ventilation In the NEOnate | Chemically-Induced Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, neonatal respiratory failure, nervous system disorder, perceptual disorders, psychiatric disorder, substance withdrawal syndrome, substance-related disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-08-26 | NCT07493785 | |
| Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET | Disease Attributes, Disease Progression, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-06-04 | NCT04954820 | |
| Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, arteriovenous hemangioma/malformation, cardiovascular disorder, vascular disorder, vascular malformation | Recruiting | Phase 2 | 2026-05-13 | NCT02042326 | |
| Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial | Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, injury, vascular disorder, venous thromboembolism | Not yet recruiting | Not applicable | 2026-04-29 | NCT07506473 | |
| Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, Spasms, Infantile, brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not stated | 2026-02-24 | NCT05126914 | |
| Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2025-11-28 | NCT04823377 | |
| Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2025-11-26 | NCT03271762 | |
| eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2025-10-14 | NCT02767804 |